News
Stylus Medicine, Inc. ("Stylus"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today emerges from stealth with $85 million in financing. Stylus' funding ...
Artificial intelligence is revolutionizing the way we care for animals. Once limited to reactive treatments at vet clinics, animal healthcare is evolving into a proactive, data-driven field where AI ...
The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching US$3.21 billion in 2025 and an impressive US$5.47 billion by 2030. The growing ...
People calling for ambulances were told they had to wait 20 h while emergency departments were struggling with record-high ...
New data from agencies collected by Sen. Joni Ernst (R-Iowa) shows inconsistent oversight of foreign risks in SBIR/STTR awards.
The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...
OFAB Ghana believes that cultivating interest in biotechnology among the youth is key to transforming Ghana’s agricultural ...
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.
NSF fellows are considered future knowledge experts who will go on to become lifelong leaders, innovators and teachers.
Bengaluru: Imagine performing surgery deep within the body using nanobots, assembling parts on a chip with high precision or ...
Discoveries made at Harvard Medical School have improved the health and lives of countless people. Today, we continue our progress toward the treatments of tomorrow.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results